HIVE vs WULF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

HIVE

48.2
AI Score
VS
WULF Wins

WULF

53.7
AI Score

Investment Advisor Scores

HIVE

48score
Recommendation
HOLD

WULF

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HIVE WULF Winner
Revenue 79.12M 12.07M HIVE
Net Income -142.91M -12.30M WULF
Gross Margin -37.3% 33.2% WULF
Net Margin -180.6% -102.0% WULF
ROE -33.8% -69.8% HIVE
ROA -15.5% -99.4% HIVE
Total Assets 924.64M 12.38M HIVE
Cash 208.04M 1.50M HIVE
Current Ratio 1.96 2.37 WULF

Relative Price Performance (Last 90 Days)

HIVE 1M: -4.7% · 3M: -21.3% WULF 1M: -22.0% · 3M: -31.8%

Current Technical Phase

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.9 · Price: $3.03

WULF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.3%), weak momentum, RSI 40

RSI (14): 39.8 · Price: $15.64

Fundamentals Snapshot

Metric HIVE WULF
Market Cap
Forward P/E -5.9 -65.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.7% -0.1%
Gross Margin 0.4% 0.7%
Operating Margin -0.6% -3.1%
EPS -1.54 -4.74
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, WULF is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.